Literature DB >> 22188201

Very poor performance status elderly patients with aggressive B cell lymphomas can benefit from intensive chemotherapy.

Stella J Bowcock, Vincenzo Fontana, Hannah E Patrick.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22188201     DOI： 10.1111/j.1365-2141.2011.08987.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Lymphomas diagnosed in an internal medicine department compared to lymphomas diagnosed in other departments: Clinical and outcome differences.

Authors:  Benoit Pernot; Emmanuel Gyan; François Maillot; Penelope Hodges; Marjan Ertault; Nicole Ferreira-Maldent
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

2.  Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma.

Authors:  Richard J Lin; Colette N Owens; Esther Drill; Augustine Iannotta; Mayan Oliveros; Dylan L Schick; Ariela Noy; John F Gerecitano; Pamela R Drullinsky; Philip C Caron; Anita Kumar; Matthew J Matasar; Craig Moskowitz; Beatriz Korc-Grodzicki; Andrew D Zelenetz; Gilles A Salles; Paul A Hamlin
Journal:  Haematologica       Date:  2022-05-01       Impact factor: 11.047
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.